Daniel F. Carr

2.5k total citations
67 papers, 1.5k citations indexed

About

Daniel F. Carr is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Daniel F. Carr has authored 67 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 13 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Daniel F. Carr's work include Drug-Induced Adverse Reactions (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Lipoproteins and Cardiovascular Health (6 papers). Daniel F. Carr is often cited by papers focused on Drug-Induced Adverse Reactions (15 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Lipoproteins and Cardiovascular Health (6 papers). Daniel F. Carr collaborates with scholars based in United Kingdom, United States and Netherlands. Daniel F. Carr's co-authors include Munir Pirmohamed, Ana Alfirevic, Andrea Jorgensen, Tjeerd van Staa, James P. Hollenberg, Gerry P McCann, Sid Gilman, Laurence McEvoy, Jennifer Campbell and David G. Lalloo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Daniel F. Carr

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel F. Carr United Kingdom 24 333 308 263 252 213 67 1.5k
B Gawrońska-Szklarz Poland 26 271 0.8× 175 0.6× 290 1.1× 357 1.4× 352 1.7× 102 1.9k
John Posner United Kingdom 26 197 0.6× 239 0.8× 189 0.7× 302 1.2× 275 1.3× 80 2.0k
Daniele Campa Italy 23 211 0.6× 151 0.5× 140 0.5× 811 3.2× 515 2.4× 73 2.0k
Monette Cotreau United States 19 79 0.2× 309 1.0× 312 1.2× 460 1.8× 359 1.7× 52 1.8k
T. Arakawa Japan 26 909 2.7× 190 0.6× 116 0.4× 301 1.2× 162 0.8× 83 1.8k
Frederick W. Fraunfelder United States 26 114 0.3× 179 0.6× 68 0.3× 302 1.2× 193 0.9× 80 2.2k
Aiping Zhang China 24 260 0.8× 90 0.3× 77 0.3× 503 2.0× 220 1.0× 101 1.8k
Christiane Rordorf Switzerland 25 431 1.3× 304 1.0× 137 0.5× 819 3.3× 291 1.4× 46 2.5k
Paola Borgiani Italy 31 168 0.5× 196 0.6× 238 0.9× 846 3.4× 173 0.8× 137 2.6k
Wei Wei Liu China 25 293 0.9× 79 0.3× 221 0.8× 447 1.8× 234 1.1× 80 1.7k

Countries citing papers authored by Daniel F. Carr

Since Specialization
Citations

This map shows the geographic impact of Daniel F. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel F. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel F. Carr more than expected).

Fields of papers citing papers by Daniel F. Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel F. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel F. Carr. The network helps show where Daniel F. Carr may publish in the future.

Co-authorship network of co-authors of Daniel F. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel F. Carr. A scholar is included among the top collaborators of Daniel F. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel F. Carr. Daniel F. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carr, Daniel F., Madison Mercado, Coral García, et al.. (2025). Synthesis and evaluation of isoquinolinyl and pyridinyl-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase to alleviate orofacial hyperalgesia in the rat. Biochemistry and Biophysics Reports. 42. 102009–102009.
2.
Moots, Robert J., Farida Fortune, Richard Jackson, et al.. (2024). Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial. Lara D. Veeken. 64(5). 2882–2891. 4 indexed citations
3.
Carr, Daniel F., Christopher R. Chin, Ryan M. West, et al.. (2024). 4-Phenyl-thiazole-based dual inhibitors of fatty acid amide hydrolase and soluble epoxide hydrolase do not alleviate orofacial inflammatory pain in female rats. SHILAP Revista de lepidopterología. 6. 100119–100119. 3 indexed citations
4.
McCaddon, Andrew, et al.. (2023). Transcobalamin receptor gene polymorphisms and mutation in an elderly population. Clinical Nutrition ESPEN. 55. 425–427. 2 indexed citations
5.
Olsson‐Brown, Anna, Vincent Yip, Lorenzo Ressel, et al.. (2023). TNF‐α induced extracellular release of keratinocyte high‐mobility group box 1 in Stevens‐Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis. The Journal of Dermatology. 50(9). 1129–1139. 8 indexed citations
6.
McEvoy, Laurence, et al.. (2023). CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study. Frontiers in Pharmacology. 14. 1178421–1178421. 2 indexed citations
7.
Olsson‐Brown, Anna, Vincent Yip, Lorenzo Ressel, et al.. (2022). TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis. Journal of Investigative Dermatology. 143(6). 1023–1030.e7. 16 indexed citations
8.
Bourgeois, Stéphane, Daniel F. Carr, Andrew P. Morris, et al.. (2021). Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration. EBioMedicine. 74. 103728–103728. 5 indexed citations
9.
McEvoy, Laurence, Daniel F. Carr, & Munir Pirmohamed. (2021). Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity. Frontiers in Pharmacology. 12. 684162–684162. 47 indexed citations
10.
Carr, Daniel F., Richard M. Turner, & Munir Pirmohamed. (2020). Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. British Journal of Clinical Pharmacology. 87(2). 237–255. 19 indexed citations
11.
Hope, William, Silvia Cicconi, Timothy Felton, et al.. (2019). Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study. Antimicrobial Agents and Chemotherapy. 63(4). 19 indexed citations
12.
Foulkes, Amy, David Watson, Daniel F. Carr, et al.. (2018). A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis. Journal of Investigative Dermatology. 139(1). 100–107. 37 indexed citations
13.
Hawcutt, Daniel B., Ben Francis, Daniel F. Carr, et al.. (2018). Susceptibility to corticosteroid-induced adrenal suppression: a genome-wide association study. The Lancet Respiratory Medicine. 6(6). 442–450. 50 indexed citations
14.
Ramsbottom, Kerry A., Daniel F. Carr, Andrew R. Jones, & Daniel J. Rigden. (2018). Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions. Molecular Immunology. 101. 488–499. 13 indexed citations
15.
Jorgensen, Andrea, et al.. (2017). The molecular genetics of chemotherapy–induced peripheral neuropathy: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 120. 127–140. 47 indexed citations
16.
Mirza, Nasir, Richard Appleton, Sasha Burn, et al.. (2015). Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Human Molecular Genetics. 24(15). 4306–4316. 20 indexed citations
17.
Carr, Daniel F., Mas Chaponda, Andrea Jorgensen, et al.. (2013). Association of Human Leukocyte Antigen Alleles and Nevirapine Hypersensitivity in a Malawian HIV-Infected Population. Clinical Infectious Diseases. 56(9). 1330–1339. 78 indexed citations
18.
Puebla-Pérez, Ana Marı́a, et al.. (2008). DIFLUOROMETIL ORNITINA Y EL EXTRACTO ACUOSO DE Bursera fagaroides EN EL MODELO DE LINFOMA MURINO L5178Y EN RATONES BALB/C: COMPARACIÓN DE SU EFECTO EN EL METABOLISMO DE LAS POLIAMINAS. Revista de salud animal. 30(2). 128–132. 3 indexed citations
19.
Alfirevic, Ana, Tracy Mills, Daniel F. Carr, et al.. (2007). Tacrine-induced liver damage: an analysis of 19 candidate genes. Pharmacogenetics and Genomics. 17(12). 1091–1100. 34 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Gawrońska-Szklarz Breakdown of academic impact, for papers by John Posner Breakdown of academic impact, for papers by Daniele Campa Breakdown of academic impact, for papers by Monette Cotreau Breakdown of academic impact, for papers by T. Arakawa Breakdown of academic impact, for papers by Frederick W. Fraunfelder Breakdown of academic impact, for papers by Aiping Zhang Breakdown of academic impact, for papers by Christiane Rordorf Breakdown of academic impact, for papers by Paola Borgiani Breakdown of academic impact, for papers by Wei Wei Liu
Rankless by CCL
2026